{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "DJ-1 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Four mutants of DJ-1, M26I, R98Q, D149A, and L166P, which were found in Parkinson's disease patients",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that these mutants were found in Parkinson's disease patients, establishing a disease mechanism connection."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Formation of homodimers or heterodimers. Human 293T cells were transfected with expression vectors for FLAG-DJ-1 and Myc-DJ-1 variants, and cell lysates were immunoprecipitated with anti-FLAG antibody and analyzed by Western blotting with anti-Myc antibody.",
          "judgment": "Yes",
          "reasoning": "The assay of dimer formation is relevant to DJ-1 function and Parkinson's disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "More than five experiments were carried out.",
          "judgment": "Yes",
          "reasoning": "The paper states that more than five experiments were carried out, indicating sufficient replicates. Wild-type DJ-1 would serve as a normal control in dimer formation assays.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Four mutants of DJ-1, M26I, R98Q, D149A, and L166P, which were found in Parkinson's disease patients [15][16][17], two mutants, C46S and C53A, that are unable to form a homodimer, and the mutant C106S, which is a mutant with a cysteine-to-serine substitution corresponding to a catalytic site for protease activity, were used for",
          "judgment": "Yes",
          "reasoning": "The paper uses known pathogenic variants (M26I, R98Q, D149A, L166P) and functional mutants (C46S, C53A, C106S) as controls, which were previously characterized.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Not explicitly stated, but the text implies quantitative analysis of dimer formation.",
          "judgment": "No",
          "reasoning": "The paper does not explicitly state statistical analyses or OddsPath calculations for the functional data.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Seven total variants were used as controls (4 pathogenic, 3 functional mutants).",
          "judgment": "Yes",
          "reasoning": "With 7 total variants used as controls (4 pathogenic and 3 functional mutants), this exceeds 10 total variants needed for moderate strength.",
          "next_step_or_outcome": "Final assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The M26I variant was analyzed using a well-established assay of dimer formation with sufficient controls and replicates. With 7 total variants used as controls and more than five experiments carried out, the evidence supports a moderate strength pathogenic classification (PS3_moderate)."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "R",
          "alt": "Q",
          "position": "98"
        },
        "variant_string_id": "DJ-1 R98Q"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Four mutants of DJ-1, M26I, R98Q, D149A, and L166P, which were found in Parkinson's disease patients",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that these mutants were found in Parkinson's disease patients, establishing a disease mechanism connection."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Formation of homodimers or heterodimers. Human 293T cells were transfected with expression vectors for FLAG-DJ-1 and Myc-DJ-1 variants, and cell lysates were immunoprecipitated with anti-FLAG antibody and analyzed by Western blotting with anti-Myc antibody.",
          "judgment": "Yes",
          "reasoning": "The assay of dimer formation is relevant to DJ-1 function and Parkinson's disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "More than five experiments were carried out.",
          "judgment": "Yes",
          "reasoning": "The paper states that more than five experiments were carried out, indicating sufficient replicates. Wild-type DJ-1 would serve as a normal control in dimer formation assays.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Four mutants of DJ-1, M26I, R98Q, D149A, and L166P, which were found in Parkinson's disease patients [15][16][17], two mutants, C46S and C53A, that are unable to form a homodimer, and the mutant C106S, which is a mutant with a cysteine-to-serine substitution corresponding to a catalytic site for protease activity, were used for",
          "judgment": "Yes",
          "reasoning": "The paper uses known pathogenic variants (M26I, R98Q, D149A, L166P) and functional mutants (C46S, C53A, C106S) as controls, which were previously characterized.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Not explicitly stated, but the text implies quantitative analysis of dimer formation.",
          "judgment": "No",
          "reasoning": "The paper does not explicitly state statistical analyses or OddsPath calculations for the functional data.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Seven total variants were used as controls (4 pathogenic, 3 functional mutants).",
          "judgment": "Yes",
          "reasoning": "With 7 total variants used as controls (4 pathogenic and 3 functional mutants), this exceeds 10 total variants needed for moderate strength.",
          "next_step_or_outcome": "Final assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The R98Q variant was analyzed using a well-established assay of dimer formation with sufficient controls and replicates. With 7 total variants used as controls and more than five experiments carried out, the evidence supports a moderate strength pathogenic classification (PS3_moderate)."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "D",
          "alt": "A",
          "position": "149"
        },
        "variant_string_id": "DJ-1 D149A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Four mutants of DJ-1, M26I, R98Q, D149A, and L166P, which were found in Parkinson's disease patients",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that these mutants were found in Parkinson's disease patients, establishing a disease mechanism connection."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Formation of homodimers or heterodimers. Human 293T cells were transfected with expression vectors for FLAG-DJ-1 and Myc-DJ-1 variants, and cell lysates were immunoprecipitated with anti-FLAG antibody and analyzed by Western blotting with anti-Myc antibody.",
          "judgment": "Yes",
          "reasoning": "The assay of dimer formation is relevant to DJ-1 function and Parkinson's disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "More than five experiments were carried out.",
          "judgment": "Yes",
          "reasoning": "The paper states that more than five experiments were carried out, indicating sufficient replicates. Wild-type DJ-1 would serve as a normal control in dimer formation assays.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Four mutants of DJ-1, M26I, R98Q, D149A, and L166P, which were found in Parkinson's disease patients [15][16][17], two mutants, C46S and C53A, that are unable to form a homodimer, and the mutant C106S, which is a mutant with a cysteine-to-serine substitution corresponding to a catalytic site for protease activity, were used for",
          "judgment": "Yes",
          "reasoning": "The paper uses known pathogenic variants (M26I, R98Q, D149A, L166P) and functional mutants (C46S, C53A, C106S) as controls, which were previously characterized.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Not explicitly stated, but the text implies quantitative analysis of dimer formation.",
          "judgment": "No",
          "reasoning": "The paper does not explicitly state statistical analyses or OddsPath calculations for the functional data.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Seven total variants were used as controls (4 pathogenic, 3 functional mutants).",
          "judgment": "Yes",
          "reasoning": "With 7 total variants used as controls (4 pathogenic and 3 functional mutants), this exceeds 10 total variants needed for moderate strength.",
          "next_step_or_outcome": "Final assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The D149A variant was analyzed using a well-established assay of dimer formation with sufficient controls and replicates. With 7 total variants used as controls and more than five experiments carried out, the evidence supports a moderate strength pathogenic classification (PS3_moderate)."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "DJ-1 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Four mutants of DJ-1, M26I, R98Q, D149A, and L166P, which were found in Parkinson's disease patients",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that these mutants were found in Parkinson's disease patients, establishing a disease mechanism connection."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Formation of homodimers or heterodimers. Human 293T cells were transfected with expression vectors for FLAG-DJ-1 and Myc-DJ-1 variants, and cell lysates were immunoprecipitated with anti-FLAG antibody and analyzed by Western blotting with anti-Myc antibody.",
          "judgment": "Yes",
          "reasoning": "The assay of dimer formation is relevant to DJ-1 function and Parkinson's disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "More than five experiments were carried out.",
          "judgment": "Yes",
          "reasoning": "The paper states that more than five experiments were carried out, indicating sufficient replicates. Wild-type DJ-1 would serve as a normal control in dimer formation assays.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Four mutants of DJ-1, M26I, R98Q, D149A, and L166P, which were found in Parkinson's disease patients [15][16][17], two mutants, C46S and C53A, that are unable to form a homodimer, and the mutant C106S, which is a mutant with a cysteine-to-serine substitution corresponding to a catalytic site for protease activity, were used for",
          "judgment": "Yes",
          "reasoning": "The paper uses known pathogenic variants (M26I, R98Q, D149A, L166P) and functional mutants (C46S, C53A, C106S) as controls, which were previously characterized.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Not explicitly stated, but the text implies quantitative analysis of dimer formation.",
          "judgment": "No",
          "reasoning": "The paper does not explicitly state statistical analyses or OddsPath calculations for the functional data.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Seven total variants were used as controls (4 pathogenic, 3 functional mutants).",
          "judgment": "Yes",
          "reasoning": "With 7 total variants used as controls (4 pathogenic and 3 functional mutants), this exceeds 10 total variants needed for moderate strength.",
          "next_step_or_outcome": "Final assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The L166P variant was analyzed using a well-established assay of dimer formation with sufficient controls and replicates. With 7 total variants used as controls and more than five experiments carried out, the evidence supports a moderate strength pathogenic classification (PS3_moderate)."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "C",
          "alt": "S",
          "position": "46"
        },
        "variant_string_id": "DJ-1 C46S"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Two mutants, C46S and C53A, that are unable to form a homodimer.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that these mutants are unable to form homodimers, establishing a disease mechanism connection related to DJ-1 function."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Formation of homodimers or heterodimers. Human 293T cells were transfected with expression vectors for FLAG-DJ-1 and Myc-DJ-1 variants, and cell lysates were immunoprecipitated with anti-FLAG antibody and analyzed by Western blotting with anti-Myc antibody.",
          "judgment": "Yes",
          "reasoning": "The assay of dimer formation is relevant to DJ-1 function and Parkinson's disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "More than five experiments were carried out.",
          "judgment": "Yes",
          "reasoning": "The paper states that more than five experiments were carried out, indicating sufficient replicates. Wild-type DJ-1 would serve as a normal control in dimer formation assays.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Four mutants of DJ-1, M26I, R98Q, D149A, and L166P, which were found in Parkinson's disease patients [15][16][17], two mutants, C46S and C53A, that are unable to form a homodimer, and the mutant C106S, which is a mutant with a cysteine-to-serine substitution corresponding to a catalytic site for protease activity, were used for",
          "judgment": "Yes",
          "reasoning": "The paper uses known pathogenic variants (M26I, R98Q, D149A, L166P) and functional mutants (C46S, C53A, C106S) as controls, which were previously characterized.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Not explicitly stated, but the text implies quantitative analysis of dimer formation.",
          "judgment": "No",
          "reasoning": "The paper does not explicitly state statistical analyses or OddsPath calculations for the functional data.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Seven total variants were used as controls (4 pathogenic, 3 functional mutants).",
          "judgment": "Yes",
          "reasoning": "With 7 total variants used as controls (4 pathogenic and 3 functional mutants), this exceeds 10 total variants needed for moderate strength.",
          "next_step_or_outcome": "Final assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_moderate"
      },
      "overall_conclusion": "The C46S variant was analyzed using a well-established assay of dimer formation with sufficient controls and replicates. With 7 total variants used as controls and more than five experiments carried out, the evidence supports a moderate strength benign classification (BS3_moderate)."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "C",
          "alt": "A",
          "position": "53"
        },
        "variant_string_id": "DJ-1 C53A"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Two mutants, C46S and C53A, that are unable to form a homodimer.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that these mutants are unable to form homodimers, establishing a disease mechanism connection related to DJ-1 function."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Formation of homodimers or heterodimers. Human 293T cells were transfected with expression vectors for FLAG-DJ-1 and Myc-DJ-1 variants, and cell lysates were immunoprecipitated with anti-FLAG antibody and analyzed by Western blotting with anti-Myc antibody.",
          "judgment": "Yes",
          "reasoning": "The assay of dimer formation is relevant to DJ-1 function and Parkinson's disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "More than five experiments were carried out.",
          "judgment": "Yes",
          "reasoning": "The paper states that more than five experiments were carried out, indicating sufficient replicates. Wild-type DJ-1 would serve as a normal control in dimer formation assays.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Four mutants of DJ-1, M26I, R98Q, D149A, and L166P, which were found in Parkinson's disease patients [15][16][17], two mutants, C46S and C53A, that are unable to form a homodimer, and the mutant C106S, which is a mutant with a cysteine-to-serine substitution corresponding to a catalytic site for protease activity, were used for",
          "judgment": "Yes",
          "reasoning": "The paper uses known pathogenic variants (M26I, R98Q, D149A, L166P) and functional mutants (C46S, C53A, C106S) as controls, which were previously characterized.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Not explicitly stated, but the text implies quantitative analysis of dimer formation.",
          "judgment": "No",
          "reasoning": "The paper does not explicitly state statistical analyses or OddsPath calculations for the functional data.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Seven total variants were used as controls (4 pathogenic, 3 functional mutants).",
          "judgment": "Yes",
          "reasoning": "With 7 total variants used as controls (4 pathogenic and 3 functional mutants), this exceeds 10 total variants needed for moderate strength.",
          "next_step_or_outcome": "Final assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_moderate"
      },
      "overall_conclusion": "The C53A variant was analyzed using a well-established assay of dimer formation with sufficient controls and replicates. With 7 total variants used as controls and more than five experiments carried out, the evidence supports a moderate strength benign classification (BS3_moderate)."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "C",
          "alt": "S",
          "position": "106"
        },
        "variant_string_id": "DJ-1 C106S"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The mutant C106S, which is a mutant with a cysteine-to-serine substitution corresponding to a catalytic site for protease activity.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that this mutant affects the catalytic site for protease activity, establishing a disease mechanism connection related to DJ-1 function."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Formation of homodimers or heterodimers. Human 293T cells were transfected with expression vectors for FLAG-DJ-1 and Myc-DJ-1 variants, and cell lysates were immunoprecipitated with anti-FLAG antibody and analyzed by Western blotting with anti-Myc antibody.",
          "judgment": "Yes",
          "reasoning": "The assay of dimer formation is relevant to DJ-1 function and Parkinson's disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "More than five experiments were carried out.",
          "judgment": "Yes",
          "reasoning": "The paper states that more than five experiments were carried out, indicating sufficient replicates. Wild-type DJ-1 would serve as a normal control in dimer formation assays.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Four mutants of DJ-1, M26I, R98Q, D149A, and L166P, which were found in Parkinson's disease patients [15][16][17], two mutants, C46S and C53A, that are unable to form a homodimer, and the mutant C106S, which is a mutant with a cysteine-to-serine substitution corresponding to a catalytic site for protease activity, were used for",
          "judgment": "Yes",
          "reasoning": "The paper uses known pathogenic variants (M26I, R98Q, D149A, L166P) and functional mutants (C46S, C53A, C106S) as controls, which were previously characterized.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Not explicitly stated, but the text implies quantitative analysis of dimer formation.",
          "judgment": "No",
          "reasoning": "The paper does not explicitly state statistical analyses or OddsPath calculations for the functional data.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Seven total variants were used as controls (4 pathogenic, 3 functional mutants).",
          "judgment": "Yes",
          "reasoning": "With 7 total variants used as controls (4 pathogenic and 3 functional mutants), this exceeds 10 total variants needed for moderate strength.",
          "next_step_or_outcome": "Final assessment"
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_moderate"
      },
      "overall_conclusion": "The C106S variant was analyzed using a well-established assay of dimer formation with sufficient controls and replicates. With 7 total variants used as controls and more than five experiments carried out, the evidence supports a moderate strength benign classification (BS3_moderate)."
    }
  ]
}